Astec LifeSciences Limited

Rachunek Zysków i Strat





Przychody TTM (mln): 3 725
EBIT TTM (mln): -1 042
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Rok finansowy 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025
Przychód (mln) 552 844 1,119 1,094 1,128 1,748 2,070 2,665 2,593 2,987 3,613 4,309 5,226 5,549 6,766 6,282 4,582 3,813
Przychód Δ r/r 0.0% 53.0% 32.6% -2.2% 3.1% 54.9% 18.4% 28.8% -2.7% 15.2% 21.0% 19.3% 21.3% 6.2% 21.9% -7.2% -27.1% -16.8%
Marża brutto 38.4% 32.6% 28.9% 22.2% 31.2% 32.6% 29.7% 31.5% 31.8% 39.8% 34.3% 34.6% 34.8% 37.8% 42.2% 36.1% 8.9% 22.1%
EBIT (mln) 95 124 172 70 18 85 111 190 -174 510 564 685 685 897 1,203 435 -422 233
EBIT Δ r/r 0.0% 31.4% 38.4% -59.5% -74.1% 372.1% 31.1% 70.2% -191.9% -392.5% 10.6% 21.4% -0.1% 31.0% 34.1% -63.9% -197.0% -155.2%
EBIT (%) 17.1% 14.7% 15.3% 6.4% 1.6% 4.9% 5.4% 7.1% -6.7% 17.1% 15.6% 15.9% 13.1% 16.2% 17.8% 6.9% -9.2% 6.1%
Koszty finansowe (mln) 0 0 0 0 0 0 79 114 115 122 107 124 126 48 91 207 252 367
EBITDA (mln) 158 216 255 158 158 263 360 536 242 662 769 901 972 1,193 1,628 893 -59 -662
EBITDA(%) 28.7% 25.6% 22.8% 14.5% 14.0% 15.1% 17.4% 20.1% 9.3% 22.2% 21.3% 20.9% 18.6% 21.5% 24.1% 14.2% -1.3% -17.4%
Podatek (mln) 14 17 33 21 5 28 25 42 16 96 207 201 138 240 312 94 -149 63
Zysk Netto (mln) 79 104 132 49 14 60 87 148 -192 191 349 357 475 650 899 256 -469 -1,348
Zysk netto Δ r/r 0.0% 30.6% 27.3% -62.9% -72.1% 335.8% 45.8% 70.3% -229.7% -199.8% 82.6% 2.4% 32.9% 36.9% 38.1% -71.5% -283.6% 187.1%
Zysk netto (%) 14.4% 12.3% 11.8% 4.5% 1.2% 3.4% 4.2% 5.5% -7.4% 6.4% 9.7% 8.3% 9.1% 11.7% 13.3% 4.1% -10.2% -35.3%
EPS 8.42 11.0 10.98 2.89 0.81 3.45 4.74 7.91 -9.85 9.81 17.88 18.28 24.29 33.23 45.87 13.04 -23.96 -68.71
EPS (rozwodnione) 8.42 11.0 10.98 2.89 0.81 3.43 4.74 7.91 -9.82 9.78 17.84 18.26 24.27 33.21 45.85 13.04 -23.96 -68.71
Ilośc akcji (mln) 9 9 12 17 17 17 18 19 19 19 20 20 20 20 20 20 20 20
Ważona ilośc akcji (mln) 9 9 12 17 17 17 18 19 20 20 20 20 20 20 20 20 20 20
Waluta INR INR INR INR INR INR INR INR INR INR INR INR INR INR INR INR INR INR